LB Pharmaceuticals, Inc. (LBRX)
48.78
+0.57
(+1.18%)
USD |
NASDAQ |
Aug 25, 16:00
48.78
0.00 (0.00%)
After-Hours: 19:59
LB Pharmaceuticals Market Cap : 1.399B for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.383B |
| August 21, 2026 | 1.366B |
| August 20, 2026 | 1.355B |
| August 19, 2026 | 1.404B |
| August 18, 2026 | 1.399B |
| August 17, 2026 | 1.326B |
| August 14, 2026 | 1.370B |
| August 13, 2026 | 1.270B |
| August 12, 2026 | 1.302B |
| August 11, 2026 | 1.300B |
| August 10, 2026 | 1.315B |
| August 07, 2026 | 1.377B |
| August 06, 2026 | 1.382B |
| August 05, 2026 | 1.291B |
| August 04, 2026 | 1.290B |
| August 03, 2026 | 1.228B |
| July 31, 2026 | 1.149B |
| July 30, 2026 | 1.173B |
| July 29, 2026 | 1.118B |
| July 28, 2026 | 1.002B |
| July 27, 2026 | 997.31M |
| July 24, 2026 | 1.004B |
| July 23, 2026 | 992.72M |
| July 22, 2026 | 1.028B |
| July 21, 2026 | 926.48M |
| Date | Value |
|---|---|
| July 20, 2026 | 886.05M |
| July 17, 2026 | 900.68M |
| July 16, 2026 | 877.16M |
| July 15, 2026 | 922.18M |
| July 14, 2026 | 918.17M |
| July 13, 2026 | 924.76M |
| July 10, 2026 | 944.83M |
| July 09, 2026 | 967.49M |
| July 08, 2026 | 979.82M |
| July 07, 2026 | 983.26M |
| July 06, 2026 | 958.03M |
| July 02, 2026 | 958.60M |
| July 01, 2026 | 914.44M |
| June 30, 2026 | 930.64M |
| June 29, 2026 | 935.95M |
| June 26, 2026 | 915.30M |
| June 25, 2026 | 888.92M |
| June 24, 2026 | 874.01M |
| June 23, 2026 | 877.45M |
| June 22, 2026 | 856.52M |
| June 18, 2026 | 860.24M |
| June 17, 2026 | 861.68M |
| June 16, 2026 | 793.14M |
| June 15, 2026 | 817.23M |
| June 12, 2026 | 814.94M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ligand Pharmaceuticals, Inc. | 5.609B |
| Neumora Therapeutics, Inc. | 277.47M |
| ANI Pharmaceuticals, Inc. | 1.737B |
| Corcept Therapeutics, Inc. | 13.33B |
| Veru, Inc. | 46.46M |
Market Cap Related Metrics
| PEG Ratio | -0.1239 |
| Price to Book Value | 4.210 |
| Price | 48.78 |
| Earnings Yield | -6.11% |
| PEGY Ratio | -0.1239 |